https://www.news-medical.net/news/20230413/MHRA-research-evaluates-two-different-approaches-to-cancer-therapies.aspx
The report 'Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue', published in the PLOS ONE journal, highlights MHRA research which showed that genetic engineering of antibodies used to activate and support the immune…
Create an account or login to join the discussion